Join us for this interactive workshop where we will focus on the target product profile (TPP) and learn how to transform it into a dynamic and strategic document driving the development of any product, for any indication. Discover the importance of crafting a TPP that is agreed upon by all key stakeholders within your organization. A compelling case study will help illustrate key concepts and foster active participation from attendees.

This workshop is designed for stakeholders across the health science field, including those involved in CMC, nonclinical, clinical, and BD/Market Access roles. Whether you're working with Medicinal Products or Devices, this workshop is relevant to anyone seeking to enhance their understanding of TPPs. Throughout the workshop, attendees will have ample opportunities to engage with the presenter and fellow participants through interactive discussions, polls, and Q&A sessions.

Key topics include:

• Understanding the applicability of TPP to different products


• Defining the TPP and its significance in product development


• Identifying the stakeholders responsible for authoring and owning the TPP


• Exploring the essential characteristics of a robust TPP


• Addressing the fundamental questions that should be covered in the TPP

Workshop agenda:

• Understanding the TPP and its value proposition


• Identifying stakeholders and their roles


• Crafting a comprehensive and actionable TPP


• Case study: applying TPP principles in real-world scenarios


• Q&A session


• Networking

Speakers

Carlo Chiavaroli, Ph.D.

Carlo has almost 30 years of experience in the drug development process over a large range of therapeutic areas. As Senior Director at VCLS in Lausanne, Carlo leads since 2011 nonclinical and early clinical challenging projects for which strategic considerations are essential.

Previously in Geneva Carlo headed the medical affairs at Med Discovery (2009-2010) and the nonclinical and early clinical development at OM Pharma (1996-2008). Carlo started his career in 1995 at the CRO Battelle.

Hubert Ridolphi, Pharm.D.

Hubert has more than 30 years’ experience in life sciences, garnered through multiple positions held in life science consultancies and Biotech companies. As a qualified Pharmacist, Hubert has the depth of knowledge to understand the complexities and challenges when developing Life Science products. Prior to joining VCLS in 2021, Hubert served as Senior e-Health Manager at ELCA and performed business development assignments in Europe for GBA Group Pharma, a prominent service provider to the clinical trial and biotech Industry.

As a former acting CEO of a Consulting firm to the Life Science Industry, providing business and operation development services to various Health Industry customers for 10 years, Hubert is an expert at providing sound guidance on both the business and scientific.

About Voisin Consulting Life Science:

At VCLS (Voisin Consulting Life Sciences), regulatory science guides Biotechnology, Pharmaceutical and Medtech manufacturers throughout product development and commercialization. Starting early in the process, from discovery to the patient, VCLS assists innovators in designing optimized product development plans and regulatory strategies, combining the health ecosystem with commercial success. With a presence in seven locations across three continents and over 280 employees, VCLS serves a broad range of healthtech developers and their investors.